Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20646 | TNG908 | 2760481-53-4 | ≧98.0% |  |
| TNG908 is a clinical stage MTA-cooperative PRMT5 inhibitor that is selectively active | ||||
| 20313 | Cenerimod ( ACT-334441 ) | 1262414-04-9 | ≧98.0% |  |
| Cenerimod is a potent and orally active immunomodulator, exhibited EC50 value of 2.7 | ||||
| 20645 | CP-506 ( Synonyms: SN-36506 ) | 2227304-19-8 | 98% Min. | _2227304-19-8.png) |
| CP-506 (SN-36506) is an hypoxia-activated prodrug of a DNA-alkylating nitrogen mustar | ||||
| 822223 | Venglustat ( ibiglustat ) | 1401090-53-6 | ≧98.0% | _1401090-53-6.png) |
| Venglustat(ibiglustat)is an oral inhibitor of an enzyme called glucosylceramide synth | ||||
| 20524 | Zidesamtinib ( NVL-520 ) | 2739829-00-4 | ≧98.0% |  |
| Zidesamtinib ( NVL-520 ) is a novel brain-penetrant ROS1-selective tyrosine kinase in | ||||
| 822224 | RP-5063（Brilaroxazine） | 1239729-06-6 | ≧98.0% |  |
| RP-5063（Brilaroxazine） is a multimodal modulator of serotonin and dopamine recept | ||||
| 20610 | Zavondemstat | 1851412-93-5 | ≧98.0% |  |
| Zavondemstat is a KDM4 inhibitor with potential as an antineoplastic agent. | ||||
| 822225 | Cadisegliatin (TTP-399) | 859525-02-3 | ≧98.0% |  |
| Cadisegliatin(TTP-399) is a potential liver-selective glucokinase (GK) activator for | ||||
| 236271 | TP1287 | 2044686-42-0 | ≧97.0% |  |
| Alvocidib Prodrug TP-1287 is an orally bioavailable, highly soluble phosphate prodrug | ||||
| 51910 | TRV130 ( Oliceridine ) | 1401031-39-7 | ≧98.0% | _1401031-39-7.png) |
| TRV 130 Hcl is a novel -opioid receptor (MOR) G protein-biased ligand; elicits robust | ||||
| 16122736 | Lirametostat ( CPI-1205 ) | 1621862-70-1 | ≧98.0% | _1621862-70-1.png) |
| Lirametostat ( CPI-1205 ) is a potent, selective, and cofactor-competitive inhibitor | ||||
| 191123 | Tafenoquine succinate | 106635-81-8 | ≧98.0% |  |
| Tafenoquine is being investigated as a potential treatment for malaria, as well as fo | ||||